Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Management of adjuvant/neoadjuvant HCC in 2024 

Update on adjuvant treatment

Date

16 Sep 2024

Session

Management of adjuvant/neoadjuvant HCC in 2024 

Topics

Tumour Site

Hepatobiliary Cancers

Presenters

Tim Meyer

Authors

T. Meyer

Author affiliations

  • Oncology Department, UCL Cancer Institute - Paul O'Gorman Building, WC1 E6JD - London/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Presentation of case/condition

Presenter: Anna Saborowski

Session: Management of adjuvant/neoadjuvant HCC in 2024 

Resources:

Slides

Webcast

Discussion

Session: Management of adjuvant/neoadjuvant HCC in 2024 

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.

  • Analytics cookies help us improve our website by collecting and reporting information on its usage.

  • We use marketing cookies to build a profile of you as a user through your actions on our site in order to better understand your interests and provide you with pertinent suggestions.